Phase I Study of Brentuximab Vedotin for the Prevention of Acute GvHD after Unrelated Allogeneic Stem Cell Transplantation
2016 ◽
Vol 22
(3)
◽
pp. S413
Mark A. Schroeder
◽
Michael P. Rettig
◽
Sarah Willey
◽
Theresa Fletcher
◽
Stephanie Meier
◽
...
2002 ◽
Vol 29
(5)
◽
pp. 373-377
◽
JH Antin
◽
SJ Lee
◽
D Neuberg
◽
E Alyea
◽
RJ Soiffer
◽
...
2012 ◽
Vol 18
(2)
◽
pp. 324-329
◽
Prakash Satwani
◽
Monica Bhatia
◽
James H. Garvin
◽
Diane George
◽
Filemon Dela Cruz
◽
...
2014 ◽
Vol 20
(5)
◽
pp. 730-734
◽
Albert C. Yeh
◽
Andrew M. Brunner
◽
Thomas R. Spitzer
◽
Yi-Bin Chen
◽
Erin Coughlin
◽
...
2013 ◽
Vol 19
(7)
◽
pp. 1040-1045
◽
Usama Gergis
◽
Gail Roboz
◽
Tsiporah Shore
◽
Ellen Ritchie
◽
Sebastian Mayer
◽
...
2009 ◽
Vol 15
(2)
◽
pp. 99
◽
W.A. Wood
◽
C.M. Walko
◽
K.V. Rao
◽
J. Whitley
◽
D.T. Moore
◽
...
2016 ◽
Vol 101
(10)
◽
pp. 1251-1259
◽
S. Nikiforow
◽
H. T. Kim
◽
H. Daley
◽
C. Reynolds
◽
K. T. Jones
◽
...
2007 ◽
Vol 92
(7)
◽
pp. 952-959
◽
M. Introna
◽
G. Borleri
◽
E. Conti
◽
M. Franceschetti
◽
A. M. Barbui
◽
...
2018 ◽
Vol 22
(6)
◽
pp. 941-950.e6
◽
Erik Curtis
◽
Joel R. Martin
◽
Brandon Gabel
◽
Nikki Sidhu
◽
Teresa K. Rzesiewicz
◽
...
2016 ◽
Vol 48
◽
pp. 6-10
◽
Yun Luo
◽
Han-Qing Zeng
◽
Yan Shen
◽
Ping Zhang
◽
Shi-Feng Lou
◽
...